Effects of Cardioprotective Therapy, Carvedilol vs Ramipril, in Patients Affected by Duchenne and Becker Muscular Dystrophy. Clinical Significance and Prognostic Value of Cardiac Magnetic Resonance Study.

Trial Profile

Effects of Cardioprotective Therapy, Carvedilol vs Ramipril, in Patients Affected by Duchenne and Becker Muscular Dystrophy. Clinical Significance and Prognostic Value of Cardiac Magnetic Resonance Study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Carvedilol (Primary) ; Ramipril (Primary)
  • Indications Cardiomyopathies
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Feb 2015 Status changed from discontinued to recruiting as per ClinicalTrials.gov record.
    • 26 Feb 2015 Planned End Date changed from 1 Dec 2011 to 1 Dec 2016 as per ClinicalTrials.gov record.
    • 20 Jun 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top